Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.755
+0.035 (2.04%)
Nov 21, 2024, 12:44 PM EST - Market open
Ventyx Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 32.18 | 32.23 | 25.4 | 8.67 | 0.68 | 0.63 |
| Research & Development | 134.2 | 175.77 | 87.74 | 58.48 | 6.37 | 3.55 |
| Operating Expenses | 166.38 | 207.99 | 113.14 | 67.15 | 7.05 | 4.18 |
| Operating Income | -166.38 | -207.99 | -113.14 | -67.15 | -7.05 | -4.18 |
| Interest Expense | - | - | - | -0.1 | -0.36 | -0.15 |
| Interest & Investment Income | 13.98 | 15.07 | 4.67 | 0.08 | - | - |
| Other Non Operating Income (Expenses) | -0.13 | -0.04 | 0.04 | -16.58 | -20.77 | -0 |
| Pretax Income | -152.52 | -192.96 | -108.43 | -83.75 | -28.17 | -4.33 |
| Net Income | -152.52 | -192.96 | -108.43 | -83.75 | -28.17 | -4.33 |
| Preferred Dividends & Other Adjustments | - | - | - | 1.55 | - | - |
| Net Income to Common | -152.52 | -192.96 | -108.43 | -85.3 | -28.17 | -4.33 |
| Shares Outstanding (Basic) | 66 | 59 | 52 | 13 | 2 | 2 |
| Shares Outstanding (Diluted) | 66 | 59 | 52 | 13 | 2 | 2 |
| Shares Change (YoY) | 13.07% | 11.57% | 309.11% | 544.96% | 19.64% | - |
| EPS (Basic) | -2.33 | -3.30 | -2.07 | -6.65 | -14.17 | -2.60 |
| EPS (Diluted) | -2.33 | -3.30 | -2.07 | -6.65 | -14.17 | -2.60 |
| Free Cash Flow | -159.73 | -167.04 | -99.05 | -38.91 | -6.2 | -2.64 |
| Free Cash Flow Per Share | -2.44 | -2.85 | -1.89 | -3.03 | -3.12 | -1.59 |
| EBITDA | -166.12 | -207.84 | -113.01 | -67.12 | - | - |
| D&A For EBITDA | 0.26 | 0.16 | 0.12 | 0.03 | - | - |
| EBIT | -166.38 | -207.99 | -113.14 | -67.15 | -7.05 | -4.18 |
Source: S&P Capital IQ. Standard template.
Financial Sources.